Fount Bio

Cambridge, United States

Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health.

$8.2M raised

Jul 2021

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Fount Bio raised?

Fount Bio has raised $8.2M in total funding. The most recent round was Series A. The last funding was announced in July 2021.

Who are Fount Bio's investors?

Fount Bio's investors include Morningside.

Where is Fount Bio headquartered?

Fount Bio is headquartered in Cambridge, United States.

What does Fount Bio do?

Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health.

What stage is Fount Bio at?

Fount Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 1, 2021.

MLA

"Fount Bio — Funding & Investors." VCBacked, July 1, 2021, https://www.vcbacked.co/company/fount-bio. Accessed July 2, 2026.

APA

VCBacked. (2021). Fount Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/fount-bio

Wikipedia (cite web)

{{cite web |title=Fount Bio — Funding & Investors |url=https://www.vcbacked.co/company/fount-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 1, 2021.